Utah State University biochemists Thomson Hallmark and Ryan Jackson, along with collaborators, published two seminal papers this week. Their findings describe the structure and function of a newly discovered CRISPR immune system that—unlike better-known CRISPR systems that deactivate foreign genes to protect cells—shuts down infected cells to thwart infection.